Abstract
Phase III study of a new, low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS19.5mg) over 5 years of use: evaluation of bleeding and dysmenorrhea
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
